Hollow Aluminum Hydroxide Modified Silica Nanoadjuvants with Amplified Immunotherapy Effects through Immunogenic Cell Death Induction and Antigen Release
Abstract
In spite of the widespread application of vaccine adjuvants in various preventive vaccines at present, the existing adjuvants are still hindered by weak cellular immunity responses in therapeutic cancer vaccines. Herein, a hollow silica nanoadjuvant containing aluminum hydroxide spikes on the surface (SiAl) is synthesized for the co‐loading of chemotherapeutic drug doxorubicin (Dox) and tumor fragment (TF) as tumor antigens (SiAl@Dox@TF). The obtained nanovaccines show significantly elevated anti‐tumor immunity responses thanks to silica and aluminum‐based composite nanoadjuvant‐mediated tumor antigen release and Dox‐induced immunogenic cell death (ICD). In addition, the highest frequencies of dendritic cells (DCs), CD4 + T cells, CD8 + T cells, and memory T cells as well as the best mice breast cancer (4T1) tumor growth inhibitory are also observed in SiAl@Dox@TF group, indicating favorable potential of SiAl nanoadjuvants for further applications. This work is believed to provide inspiration for the design of new‐style nanoadjuvants and adjuvant‐based cancer vaccines.Keywords
Funding Information
- National Natural Science Foundation of China (51720105015, 51929201, 51922097, 51772124, 51872282, 52102354, 52102180)
This publication has 54 references indexed in Scilit:
- Mesoporous Silica Nanoparticles Act as a Self‐Adjuvant for Ovalbumin Model Antigen in MiceSmall, 2013
- Mechanism of Immunopotentiation and Safety of Aluminum AdjuvantsFrontiers in Immunology, 2013
- Adjuvant Properties of Mesoporous Silica Particles Tune the Development of Effector T CellsSmall, 2012
- Antigen depot is not required for alum adjuvanticityThe FASEB Journal, 2011
- Effect of gold nanoparticle morphology on adsorbed protein structure and functionBiomaterials, 2011
- Rattle-type silica colloidal particles prepared by a surface-protected etching processNano Research, 2009
- Innate-immunity cytokines induced by very small size proteoliposomes, a Neisseria-derived immunological adjuvantClinical and Experimental Immunology, 2007
- Costimulatory Molecules as Adjuvants for ImmunotherapyFrontiers in Bioscience-Landmark, 2006
- Aluminium compounds for use in vaccinesImmunology & Cell Biology, 2004
- Aluminum compounds as vaccine adjuvantsAdvanced Drug Delivery Reviews, 1998